Therefore, in this study, instead of mutually exclusive classification, we aimed to define several non-mutually exclusive genetic signatures to describe and understand the complex molecular features of DLBCL, based on molecular information that was feasible to obtain including MYC/BCL2/BCL6 translocations as well as mutation data from a limited panel of genes. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.